ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 633

$1.27M Total Retail Price of All Prescriptions

Rank: 2 out of 633

1,173 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 1,173 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 1,173 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,365 1,199 249 1 1
OMEPRAZOLE 994 811 209 2 2
SIMVASTATIN 901 834 202 3 3
FUROSEMIDE 729 685 140 4 6
POTASSIUM CHLORIDE 688 668 147 5 11
LISINOPRIL 638 593 128 6 5
AMLODIPINE BESYLATE 600 575 125 7 4
TRAMADOL HCL 596 552 131 8 15
LOSARTAN POTASSIUM 585 580* 119 9 17
WARFARIN SODIUM 581 570 100 10 7
HYDROCHLOROTHIAZIDE 549 544* 143 11 14
METOPROLOL TARTRATE 547 500 127 12 12
ATORVASTATIN CALCIUM 519 461 117 13 9
CARVEDILOL 468 463* 84 14 18
GABAPENTIN 460 418 84 15 16
METFORMIN HCL 436 372 96 16 10
POLYETHYLENE GLYCOL 3350 432 385 92 17 29
PRAVASTATIN SODIUM 422 409 113 18 21
ENALAPRIL MALEATE 418 403 91 19 42
NAMENDA 417 402 33 20 34
HYDROCODONE-ACETAMINOPHEN 389 354 80 S3 21 8
CITALOPRAM HBR 348 333 57 22 20
FAMOTIDINE* 339 296 60 23 66
ATENOLOL 307 288 67 24 22
ALLOPURINOL 295 281 61 25 25
BISOPROLOL FUMARATE 280 262 54 26 88
DONEPEZIL HCL 275 270* 45 27 33
SERTRALINE HCL 262 201 50 28 19
METOPROLOL SUCCINATE 253 223 57 29 13
TAMSULOSIN HCL 225 188 45 30 24
MELOXICAM 224 203 60 31 23
PANTOPRAZOLE SODIUM 222 189 64 32 28
ISOSORBIDE MONONITRATE ER 217 205 32 33 58
QUETIAPINE FUMARATE 212 201 35 A 34 57
SPIRONOLACTONE 211 211 42 35 44
AMITRIPTYLINE HCL 209 187 35 R 36 71
LOSARTAN-HYDROCHLOROTHIAZIDE 206 178 46 37 43
CLOPIDOGREL 206 168 43 37 30
GLIMEPIRIDE 199 166 41 39 38
FENTANYL 191 186* 25 S2 40 46
PREDNISONE 189 178 58 41 36
FLUTICASONE PROPIONATE 187 151 61 42 39
LOVASTATIN 181 157 30 43 70
LORAZEPAM 178 158 43 B 44 37
ZOLPIDEM TARTRATE 157 152* 43 45 26
MONTELUKAST SODIUM 156 119 28 46 59
TORSEMIDE 153 148* 27 47 110
ALENDRONATE SODIUM 146 116 26 48 35
TRIAMTERENE-HCTZ 145 130 28 49 49
PAROXETINE HCL 145 133 31 49 74
SPIRIVA 144 124 34 51 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 138* 33 52 31
SYMBICORT 140 126 35 53 119
CLONIDINE HCL 135 130* 37 54 65
TRAZODONE HCL 130 117 33 55 48
CLONAZEPAM 127 122* 24 B 56 54
CIPROFLOXACIN HCL 124 119* 90 57 75
CARBIDOPA-LEVODOPA 123 123 23 58 89
CRESTOR 119 87 22 59 27
AMOXICILLIN 115 96 51 60 127
ADVAIR DISKUS 113 90 25 61 51
ESCITALOPRAM OXALATE 110 98 24 62 40
VERAPAMIL ER 109 70 21 63 100
MIRTAZAPINE 108 88 32 64 56
PRAMIPEXOLE DIHYDROCHLORIDE 108 89 17 64 155
CYMBALTA 106 101* 14 66 41
LEVEMIR FLEXPEN 103 86 26 67 168
DILTIAZEM 24HR ER 102 90 18 68 112
PIOGLITAZONE HCL 102 97* 23 R 68 62
SPIRONOLACTONE-HCTZ 100 100 20 70 203
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 71 38 71 87
DIOVAN 96 91* 14 72 52
LANTUS 94 89* 20 73 53
DETROL LA 91 <11 <11 74 104
ROPINIROLE HCL 90 85* 18 75 63
PROPRANOLOL HCL 90 90 19 75 106
LEVOFLOXACIN 88 83* 66 77 83
OXYBUTYNIN CHLORIDE 87 82* 19 78 93
ABILIFY 87 46 12 A 78 97
BD ULTRA-FINE PEN NEEDLE 86 72 28 80 143
ALPRAZOLAM 86 81* 26 B 80 32
TRIAMCINOLONE ACETONIDE 85 80* 41 82 95
EVISTA 81 76* 17 83 113
AZITHROMYCIN 80 75* 57 84 84
DICLOFENAC SODIUM 78 53 17 85 102
DOXAZOSIN MESYLATE 77 77 22 86 86
SYNTHROID 77 72* 16 86 64
BACLOFEN 77 52 16 86 136
HYDRALAZINE HCL 76 71* 13 89 153
GEMFIBROZIL 74 57 17 90 117
NYSTATIN 73 68* 19 91 196
BUSPIRONE HCL 72 61 11 92 128
LYRICA 71 58 12 93 81
KLOR-CON M10 71 <11 <11 93 151
BUMETANIDE 70 65* 21 95 139
HUMALOG 69 58 15 96 167
FENOFIBRATE* 68 55 11 97 60
RISPERIDONE 67 62* 13 A 98 79
LANTUS SOLOSTAR 67 47 18 98 91
RANITIDINE HCL 67 47 14 98 45
THEOPHYLLINE ANHYDROUS 63 <11 <11 101 287
CEPHALEXIN 63 58* 40 101 72
METFORMIN HCL ER 62 62 15 103 68
NIFEDIPINE ER 61 <11 <11 104 221
AMIODARONE HCL 61 61 15 104 148
ALBUTEROL SULFATE 58 <11 <11 106 108
NOVOLOG FLEXPEN 57 40 21 107 188
BUPROPION XL 56 <11 <11 108 141
VENLAFAXINE HCL ER 56 <11 <11 108 73
DOXYCYCLINE HYCLATE 54 49* 38 110 177
CEFPROZIL 53 48* 47 111 307
LATANOPROST 52 <11 <11 112 219
TERAZOSIN HCL 52 52 11 112 103
NAPROXEN 52 <11 <11 112 104
NITROGLYCERIN PATCH 51 <11 <11 115 187
KLOR-CON 10 50 45* 18 116 125
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.